Page 5 of 8
The Journal of Organic Chemistry
Procedure for the Preparation of Pyridone 3a on 10 mmol
Hz), 131.3 (d, J = 8.6 Hz), 123.8 (d, J = 2.9 Hz), 117.4, 116.4
(d, J = 20.1 Hz), 115.7 (d, J = 23 Hz), 109.5, 61.1, 19.6, 14.3;
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C15H15O3NF
276.1030, found 276.1028.
1
2
3
4
5
6
7
8
Scale. To a mixture of [RuCl2(p-cymene)]2 (0.5 mmol; 306
mg) and KOAc (1 mmol; 98 mg) in a two-neck round-bottom
flask was added 1,4-dioxane (100 mL; 0.1M) under argon
atmosphere and the reaction mixture was stirred for 1 h at rt.
N-Phenyl arylamide (1a, 10 mmol; 1.47 gm), ethyl 2-
butynoate (2a, 20 mmol; 2.24 mL) and Oxone (20 mmol; 6.15
gm) were added to the above mixture and the glass tube was
placed in preheated oil bath at 110 oC for 30 h. The progress of
the reaction was monitored by TLC. After complete consump-
tion of acrylamide 1a (30 h) the reaction mixture was cooled
to rt, diluted with ethyl acetate, filtered through short pad of
celite, and the filtrate was evaporated under vacuo to dryness.
The resulting residue was purified by column chromatography
to afford pure pyridone 3a (1.13 g; 44%).
Ethyl 1-(4-(methoxycarbonyl) phenyl)-2-methyl-6-oxo-1,6-
dihydropyridine-3-carboxylate (3e). According to the general
procedure-1, the title compound 3e was obtained as a thick
oil (44 mg; 47% yield); reaction time: 30 h; Rf: 0.5 (2:3
EtOAc: Pet. ether); 1H NMR (400 MHz, CDCl3) δ (ppm) 8.23
(d, J = 8.7 Hz, 2H), 7.99 (d, J = 10.1 Hz, 1H), 7.27 (d, J = 8.7
Hz, 2H), 6.54 (d, J = 9.6 Hz, 1H), 4.32 (q, J = 7.3 Hz, 2H),
3.96 (s, 3H), 2.37 (s, 3H), 1.38 (t, J = 7.3 Hz, 3H); 13C{1H}
NMR (100 MHz, CDCl3) δ (ppm) 165.96, 165.4, 162.98,
153.2, 142.4, 140.7, 131.4, 130.96, 128.1, 117.4, 109.5, 61.1,
52.4, 19.7, 14.3; HRMS (ESI-TOF) m/z: [M+H]+ calcd for
C17H18O5N 316.1179, found 316.1178.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ethyl
2-methyl-6-oxo-1-phenyl-1,6-dihydropyridine-3-
carboxylate (3a). According to the general procedure-1, the
title compound 3a was obtained as a thick oil (35 mg; 45%
Ethyl
1-(4-methoxyphenyl)-2-methyl-6-oxo-1,6-
dihydropyridine-3-carboxylate (3f). According to the general
procedure-1, the title compound 3f was obtained as a thick oil
(39 mg; 45% yield); reaction time: 30 h; Rf: 0.5 (2:3 EtOAc:
1
yield); reaction time: 30 h; Rf: 0.5 (2:3 EtOAc: Pet. ether); H
NMR (400 MHz, CDCl3) δ (ppm) 7.98 (d, J = 9.8 Hz, 1H),
7.55 (t, J = 7.3 Hz, 2H), 7.48 (t, J = 7.3 Hz, 1H), 7.16 (d, J =
7.3 Hz, 2H), 6.53 (d, J = 9.8 Hz, 1H), 4.32 (q, J = 6.7 Hz, 2H),
2.37 (s, 3H), 1.37 (t, J = 6.7 Hz, 3H); 13C{1H} NMR (100
MHz, CDCl3) δ (ppm) 165.5, 163.3, 153.9, 140.4, 138.4, 130,
129.1, 127.7, 117.3, 109.2, 60.9, 19.7, 14.3; HRMS (ESI-
TOF) m/z: [M+Na]+ calcd for C15H15O3NNa 280.0944, found
280.0943.
1
Pet. ether); H NMR (400 MHz, CDCl3) δ (ppm) 7.97 (d, J =
9.6 Hz, 1H), 7.09-7.03 (m, 4H), 6.54 (d, J = 9.6 Hz, 1H), 4.32
(q, J = 6.9 Hz, 2H), 3.86 (s, 3H), 2.40 (s, 3H), 1.38 (t, J = 6.9
Hz, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ (ppm) 165.6,
163.6, 159.8, 154.4, 140.4, 130.9, 128.7, 117.2, 115.2, 109.3,
60.9, 55.5, 19.7, 14.3; HRMS (ESI-TOF) m/z: [M+H]+ calcd
for C16H18O4N 288.1230, found 288.1227.
Ethyl
2-methyl-6-oxo-1-(p-tolyl)-1,6-dihydropyridine-3-
Ethyl
1-benzyl-2-methyl-6-oxo-1,6-dihydropyridine-3-
carboxylate (3b). According to the general procedure-1, the
title compound 3b was obtained as a thick oil (34 mg; 42%
carboxylate (3g). According to the general procedure-1, the
title compound 3g was obtained as a thick oil (45 mg; 55%
1
1
yield); reaction time: 30 h; Rf: 0.5 (2:3 EtOAc: Pet. ether); H
yield); reaction time: 30 h; Rf: 0.5 (2:3 EtOAc: Pet. ether); H
NMR (400 MHz, CDCl3) δ (ppm) 7.97 (d, J = 9.6 Hz, 1H),
7.34 (d, J = 8.7 Hz, 2H), 7.04 (d, J = 8.3 Hz, 2H), 6.53 (d, J =
9.2 Hz, 1H), 4.31 (q, J = 7.3 Hz, 2H), 2.43 (s, 3H), 2.38 (s,
3H), 1.37 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (100 MHz,
CDCl3) δ (ppm) 165.6, 163.4, 154.2, 140.3, 139.1, 135.7,
130.7, 127.4, 117.2, 109.2, 60.9, 21.2, 19.7, 14.3; HRMS
(ESI-TOF) m/z: [M+H]+ calcd for C16H18O3N 272.1281, found
272.1280.
NMR (400 MHz, CDCl3) δ (ppm) 7.94 (d, J = 9.6 Hz, 1H),
7.35-7.25 (m, 3H), 7.13 (d, J = 7.3 Hz, 2H), 6.56 (d, J = 9.6
Hz, 1H), 5.45 (s, 2H), 4.29 (q, J = 6.9 Hz, 2H), 2.72 (s, 3H),
1.36 (t, J = 6.9 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ
(ppm) 165.7, 163.2, 153.9, 140.1, 135.7, 128.9, 127.5, 126.3,
116.6, 109.9, 60.96, 47.5, 17.7, 14.3; HRMS (ESI-TOF) m/z:
[M+H]+ calcd for C16H18O3N 272.1281, found 272.1279.
Ethyl 1,2-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxylate
(3h). According to the general procedure-1, the title com-
pound 3h was obtained as a thick oil (34 mg; 58% yield); reac-
tion time: 30 h; Rf: 0.5 (1:1 EtOAc: Pet. ether); 1H NMR (400
MHz, CDCl3) δ (ppm) 7.87 (d, J = 9.8 Hz, 1H), 6.45 (d, J =
9.8 Hz, 1H), 4.29 (q, J = 7.3 Hz, 2H), 3.60 (s, 3H), 2.78 (s,
3H), 1.35 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (100 MHz,
CDCl3) δ (ppm) 165.7, 163.2, 153.6, 139.6, 116, 109.6, 60.9,
31.6, 17.9, 14.2; HRMS (ESI-TOF) m/z: [M+H]+ calcd for
C10H14O3N 196.0968, found 196.0967.
Ethyl
2-methyl-6-oxo-1-(3-(trifluoromethyl)phenyl)-1,6-
dihydropyridine-3-carboxylate (3c). According to the general
procedure-1, the title compound 3c was obtained as a thick
oil (46 mg; 47% yield); reaction time: 30 h; Rf: 0.5 (2:3
EtOAc: Pet. ether); 1H NMR (400 MHz, CDCl3) δ (ppm) 8.01
(d, J = 9.8 Hz, 1H), 7.77 (d, J = 7.9 Hz, 1H), 7.70 (t, J = 7.9
Hz, 1H), 7.47 (s, 1H), 7.40 (d, J = 7.9 Hz, 1H), 6.55 (d, J = 9.8
Hz, 1H), 4.33 (q, J = 7.3 Hz, 2H), 2.37 (s, 3H), 1.38 (t, J = 7.3
Hz, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ (ppm) 165.3,
163, 153.2, 140.9, 138.9, 132.7 (q, J = 33 Hz), 131.6, 130.7,
126.2 (q, J = 3 Hz), 125.1 (q, J = 3 Hz), 123.3 (q, J = 273 Hz),
117.5, 109.9, 61.1, 19.8, 14.3; HRMS (ESI-TOF) m/z:
[M+Na]+ calcd for C16H14O3NF3Na 348.0818, found 348.0815.
Ethyl
2-methyl-6-oxo-1-propyl-1,6-dihydropyridine-3-
carboxylate (3i). According to the general procedure-1, the
title compound 3i was obtained as a thick oil (32 mg; 48%
1
yield); reaction time: 30 h; Rf: 0.5 (1:1 EtOAc: Pet. ether); H
Ethyl 1-(3-fluorophenyl)-2-methyl-6-oxo-1,6-dihydropyridine-
3-carboxylate (3d). According to the general procedure-1,
the title compound 3d was obtained as a thick oil (35 mg; 42%
NMR (400 MHz, CDCl3) δ (ppm) 7.84 (d, J = 9.8 Hz, 1H),
6.42 (d, J = 9.8 Hz, 1H), 4.28 (q, J = 7.3 Hz, 2H), 4.06 (t, J =
7.3 Hz, 2H), 2.80 (s, 3H), 1.77-1.64 (m, 2H), 1.35 (t, J = 7.3
Hz, 3H), 1.01 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (100 MHz,
CDCl3) δ (ppm) 165.8, 162.9, 153, 139.6, 116.5, 109.5, 60.9,
46.2, 21.6, 17.2, 14.3, 11.3; HRMS (ESI-TOF) m/z: [M+H]+
calcd for C12H18O3N 224.1281, found 224.1280.
1
yield); reaction time: 30 h; Rf: 0.5 (2:3 EtOAc: Pet. ether); H
NMR (400 MHz, CDCl3) δ (ppm) 7.99 (d, J = 10.1 Hz, 1H),
7.57-7.48 (m, 1H), 7.21 (td, J = 8.2, 2.8 Hz, 1H), 6.98 (dt, J =
7.8, 1 Hz, 1H), 6.94 (dt, J = 8.7, 2.3 Hz, 1H), 6.53 (d, J = 9.6
Hz, 1H), 4.33 (q, J = 6.9 Hz, 2H), 2.40 (s, 3H), 1.38 (t, J = 6.9
Hz, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ (ppm) 165.4,
163.3 (d, J = 249.2 Hz), 163, 153.5, 140.7, 139.7 (d, J = 10.5
Ethyl
2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate
(3j).10 According to the general procedure-1 and by using
acrylamide and N-acetyl acrylamide, the title compound 3j
ACS Paragon Plus Environment